Novel Options for Cardiovascular Risk Reduction in Patients with Hypertriglyceridemia
This webcast includes an integrated case presentation designed to facilitate learner interaction and active participation. Patient cases illustrate residual CV risk and the need for additional therapy for reducing the risk of cardiovascular events. Learners will review the latest evidence with omega-3 fatty acids and identify patients who are appropriate candidates for treatment to reduce CV risk.
The target audience for this CME initiative is primary care providers (IM/FP/GP-MD/DO) and NP/PAs in primary care settings.
Assess the role of elevated triglycerides (TG) and their contribution to residual cardiovascular risk in patients with dyslipidemia
Review the safety and efficacy of omega-3 fatty acids for reducing the risk cardiovascular (CV) events
Apply the latest evidence to identify dyslipidemia patients who would be appropriate candidates for CV risk reduction with omega-3 fatty acid
Activity Launch Date - 10/31/19
Expiration Date - 10/31/20
Disclosure of Commercial Support
This activity is supported by an independent educational grant from Amarin.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Statement of Independence
Horizon CME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Horizon CME to develop and present educational activities that are timely, fair balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome comments about how to better serve your needs.
Copyright © 2019 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.